Explore the Journal of Drugs in Dermatology (JDD), a monthly peer-reviewed, PubMed® indexed dermatology journal & online resource.
Complimentary subscriptions for US dermatologists, dermatology residents, nurse practitioners and physician assistants.
In skin of color, halo phenomena can mask benign lesions; biopsy and dermoscopic‑pathologic correlation remain essential It’s time to dive into one of our January JDD case reports ! A…
Barrier boost for acne care: A new gel moisturizer soothes, strengthens and lifts quality of life We’re highlighting a December 2025 article that features one of JDD’s most sought-after topics:…
Aesthetics Is Changing. Here’s What We’re Seeing? Most dermatologists have experienced a shift in patient preferences over the past several years. There is a shift toward a minimalist, natural appearance.…
Trials fall short on representation - Black patients underenrolled in MF/SS studies The February issue of JDD features a review of completed US interventional trials for mycosis fungoides and Sézary syndrome…
Case report shows dual IL‑17A/F blockade produced striking clinical and functional gains within one month in refractory ACH The February 2026 JDD issue features a case report about a 67‑year‑old…
Combined Relabotulinum Toxin A frontalis modulation with NASHA™ gel skinboosters for the temples yields natural‑looking wrinkle softening and lasting skin quality gains beyond six months The Oncoderm Resource Center on…